Skip to main content

D. E. Shaw & Co., Inc.

Position in IBRX — ImmunityBio, Inc.

CIK 1009207 New York, NY

Position in IBRX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$96,424,148
+$95,798,080 QoQ
Shares Held
12,571,597
+5201.2% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IBRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. IBRX ranks #11 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IBRX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $96,424,148 12,571,597
2025-06-30 $626,068 237,147
2024-09-30 $1,934,597 520,053
2024-03-31 $1,270,724 236,634
2023-12-31 $2,967,327 591,101
2022-09-30 $3,372,163 678,504
2022-06-30 $1,527,717 410,677
2022-03-31 $534,452 95,268
2021-12-31 $2,009,446 330,501
2021-09-30 $3,676,557 377,470
2021-06-30 $1,204,832 84,372